LCM Capital Management’s Astera Labs ALAB Stock Holding History

LCM Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,571	Closed	-$261K	–	116
2025 Q4	$261K	Sell	1,571 -489	-24%	-$81.8K	0.13%	84
2025 Q3	$403K	Buy	+2,060	New	+$339K	0.19%	62

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

LCM Capital Management's ALAB Position: Q1 2026 in Review

LCM Capital Management sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 1,571 shares — an estimated $261K sold.

LCM Capital Management first reported a position in ALAB in Q3 2025 and held it in 2 quarters. The position peaked at $403K in Q3 2025. 708 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

LCM Capital Management reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
LCM Capital Management sold 1,571 Astera Labs shares in Q1 2026, an estimated $261K.
LCM Capital Management first reported a position in Astera Labs in Q3 2025 and held it in 2 quarters.
LCM Capital Management's Astera Labs position peaked at $403K in Q3 2025.
708 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on LCM Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.